INS and Glucose intolerance: They offer potential therapeutic benefits in managing MetS and diabetes by enhancing insulin sensitivity, correcting glucose intolerance, normalizing lipid profiles, and reducing hypertension (Naseri et al., 2018; Jiang et al., 2019).